The relevance of intrinsic subtype to clinicopathological features and prognosis in 4,266 Japanese women with breast cancer

Breast Cancer

Volumn 18, Issue 4, 2011, Pages 292-298

  Shibuta, Kenji ^a   Ueo, Hiroaki ^a   Furusawa, Hidemi ^b   Komaki, Kansei ^b   Rai, Yoshiaki ^c   Sagara, Yoshiatsu ^c   Kamada, Yoshihiko ^d   Tamaki, Nobumitsu ^d  

^a Ueo Breast Surgery Hospital   (Japan)

^b Breastopia Namba Hospital   (Japan)

^c SAGARA HOSPITAL   (Japan)

^d Nahanishi Clinic   (Japan)

Author keywords

Breast cancer; Clinicopathological feature; Intrinsic subtype; Japanese; Prognosis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER CLASSIFICATION; CANCER GRADING; CANCER SIZE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; JAPANESE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PAGET NIPPLE DISEASE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; TRIPLE NEGATIVE BREAST CANCER;

ADULT; AGED; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; JAPAN; MIDDLE AGED; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 82155187152     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/s12282-010-0209-6     Document Type: Article

References (19)

1. Japanese Breast Cancer Society. General rules for clinical and pathological recording of breast cancer. 15th ed. Tokyo: Kanehara-Shuppan Co.; 2004; p. 31-68.
2. National Registration Survey of Breast Cancer Patients (2005 annual cases). Japanese Breast Cancer Society Registration Committee. 2005;36:1-20 (in Japanese).
3. T Sorlie CM Perou R Tibshirani T Aas S Geisler H Johnsen, et al. 2001 Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci USA 98 10869 10874 11553815 10.1073/pnas.191367098 1:CAS:528:DC%2BD3MXntVGmsbo%3D (Pubitemid 32878711)
4. C Sotiriou SY Neo LM McShane EL Korn PM Long A Jazaeri, et al. 2003 Breast cancer classification and prognosis based on gene expression profiles from a population-based study Proc Natl Acad Sci USA 100 10393 10398 12917485 10.1073/pnas.1732912100 1:CAS:528:DC%2BD3sXntFynsrk%3D (Pubitemid 37071889)
5. CM Perou T Sorlie MB Eisen M van de Rijn SS Jefferey CA Rees, et al. 2000 Molecular portraits of human breast tumors Nature 406 747 752 10963602 10.1038/35021093 1:CAS:528:DC%2BD3cXmt1CnsLw%3D
6. T Sorlie R Tibshirani J Parker T Hastie JS Marron A Nobel, et al. 2003 Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci USA 100 8418 8423 12829800 10.1073/pnas.0932692100 1:CAS:528:DC%2BD3sXlsFGntLk%3D (Pubitemid 36842560)
7. TO Nielsen FD Hsu K Jensen M Cheang G Karaca Z Hu, et al. 2004 Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma Clin Cancer Res 10 5367 5374 15328174 10.1158/1078-0432.CCR-04-0220 1:CAS:528:DC%2BD2cXmvFSlt7k%3D (Pubitemid 39100473)
8. LA Carey CM Perou CA Livasy LG Dressler D Cowan K Conway, et al. 2006 Race, breast cancer subtypes, and survival in the Carolina breast cancer study JAMA 295 2492 2502 16757721 10.1001/jama.295.21.2492 1:CAS:528: DC%2BD28XlsV2rtLw%3D (Pubitemid 43854964)
9. Nakajima H, Fujiwara I, Mizuta N, Sakaguchi K, Hachimine Y, Nakatsukasa K, et al. Investigation of the prognosis of breast cancer from the view point of presentation of estrogen receptor and HER2 in immunohistochemical staining. Jpn Clin Surg. 2007;68:2171-77 (in Japanese with English abstract).
10. R Nishimura N Arima 2008 Is triple negative a prognostic factor in breast cancer? Breast Cancer 15 303 308 18369692 10.1007/s12282-008-0042-3
11. J Kurebayashi T Moriya T Ishida H Hirakawa M Kurosumi F Akiyama, et al. 2007 The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different races Breast 16 s72 s77 17714947 10.1016/j.breast.2007.07. 017 (Pubitemid 350028561)
12. Kurebayashi J. Characteristics of breast cancers in Japanese patients according to the gene expression profiles. Clin Surg. 2008;63:1055-9 (in Japanese).
13. A Ishihara H Tsuda K Kitagawa M Yoneda T Shiraishi 2009 Morphological characteristics of basal-like subtype of breast carcinoma with special reference to cytopathological features Breast Cancer 16 179 185 19466513 10.1007/s12282-009-0108-x
14. Okumura Y, Nishimura R, Osako T. Is chemotherapy necessary for young women with breast cancer? Jpn J Breast Cancer. 2009;24:23-9 (in Japanese with English abstract).
15. +) phenotype of BRCA1-related breast cancer Cancer Res 64 830 835 14871808 10.1158/0008-5472.CAN-03-2970 1:CAS:528:DC%2BD2cXhtFCgtLo%3D (Pubitemid 38176880)
16. C Liedtke C Mazouni KR Hess F Andre A Tordai JA Mejia, et al. 2008 Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer J Clin Oncol 26 1275 1281 18250347 10.1200/JCO.2007.14.4147
17. EA Rakha JS Reis-Filho IO Ellis 2008 Basal-like breast cancer: a critical review J Clin Oncol 26 2568 2581 18487574 10.1200/JCO.2007.13.1748
18. GMJ Piccart M Procter JB Leyland A Goldhirsch M Untch I Smith, et al. 2005 Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer N Engl J Med 353 1659 1672 10.1056/NEJMoa052306 (Pubitemid 41464705)
19. EH Romond EA Perez JB Bryant VJ Suman CE Geyer NE Davidson, et al. 2005 Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer N Engl J Med 353 1673 1684 16236738 10.1056/NEJMoa052122 1:CAS:528: DC%2BD2MXhtFansr3F (Pubitemid 41464706)